Our immune-related transcriptomic analysis based on granulosa cell data revealed substantial heterogeneity in immune signaling activity among PCOS patients, particularly pronounced in the PLK2-high subgroup. The gene discussed is PLK2; the disease is polycystic ovary syndrome.